ATRS

Q: What is the price of Antares Pharma (ATRS) today?

The current price of Antares Pharma (ATRS) is $ 0.00, representing a 0% gain over the past year. The stock began the year trading around $ 0.00 and is currently priced at $ 0.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Antares Pharma (ATRS) pay dividends?

Antares Pharma (ATRS) did not pay dividends over the past year.

Antares Pharma Inc.

Price

$ -

return (12m)

0.00%

p/e

24.23

p/bv

5.54

DIVIDEND YIELD

0.00%

ATRS price

ATRS

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ATRS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ATRS

review the fundamentals of Antares Pharma shares

P/E

24.23

Sector: -2.44 Industry: 10.87

P/S (PSR)

5.78

Sector: 1.91 Industry: 1.57

P/BV

5.54

Sector: 2.11 Industry: 3.07

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: 0.01%

ROA

15.71%

Sector: -26.27% Industry: 2.70%

ROE

22.86%

Sector: -30.97% Industry: 5.25%

ROIC

Sector: -416.93% Industry: -2.27%

NET MARGIN

23.87%

Sector: -28.25% Industry: 2.71%

GROSS MARGIN

87.95%

Sector: 44.36% Industry: 28.76%

OPERATING MARGIN

32.76%

Sector: -23.34% Industry: 1.39%

EV/EBITDA

17.13

Sector: -0.76 Industry: 3.98

EV/EBIT

18.41

Sector: -1.95 Industry: 2.39

PRICE-TO-ASSETS

3.81

Sector: 1.12 Industry: 1.42

BVPS

1.01

Sector: 3.79 Industry: 11.41

EPS

0.23

Sector: -0.92 Industry: 1.09

EQUITY-TO-ASSETS RATIO

0.69

Sector: 0.43 Industry: 0.46

LIABILITIES / ASSETS

0.69

Sector: 0.46 Industry: 0.52

CAGR REVENUE 5 YEARS

-0.06%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-2.79%

Sector: - Industry: -

FAIR VALUE OF Antares Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ATRS

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.20	34.79	86.53%	0.67%	$ 829.69 B	31.66%
ISRG	58.32	9.28	15.92%	0.00%	$ 166.57 B	28.38%
TMO	29.53	3.70	12.52%	0.33%	$ 198.00 B	15.05%
SNY	12.86	1.40	10.86%	4.60%	$ 117.31 B	18.68%
NVS	20.81	6.25	30.04%	4.59%	$ 291.02 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	23.97	2.25	9.38%	3.30%	$ 110.58 B	13.00%
GSK	15.37	5.49	35.71%	3.00%	$ 117.24 B	17.48%
CVS	55.53	1.30	2.35%	3.44%	$ 98.17 B	0.44%
BSX	32.87	0.00	0.00%	0.00%	$ 95.25 B	14.44%
TMDX	20.70	8.33	40.22%	0.00%	$ 3.94 B	31.43%
HCA	16.40	-40.15	-244.82%	0.60%	$ 111.26 B	8.97%
IDXX	44.49	29.36	65.99%	0.00%	$ 47.14 B	24.62%
RMD	22.41	5.27	23.51%	1.02%	$ 33.31 B	27.53%
DHR	38.10	2.62	6.88%	0.66%	$ 137.69 B	14.71%
INMD	9.84	1.35	13.73%	0.00%	$ 922.95 M	25.32%
PHG	27.23	2.20	8.06%	2.98%	$ 28.25 B	5.07%
FMS	11.87	0.80	6.75%	3.36%	$ 13.40 B	5.02%
SYK	40.51	5.86	14.48%	0.99%	$ 131.49 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ATRS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Antares Pharma

Antares Pharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

21 years

Founded: 2005

1996

Time since IPO - 30 years

185

Employees

Antares Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $973.27 Millions, with shareholders equity totaling $175.77 Millions.

The company employs approximately 185 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Antares Pharma Inc. reported $168.33 Millions in revenue, generating net income of $40.18 Millions.

Key financial metrics include a P/E ratio of 24.23, a price-to-book (P/B) ratio of 5.54, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ATRS.

Market cap

$ 973.27 Millions

Net worth

$ 175.77 Millions

$ 175,768,000.00

Assets

$ 255.66 Millions

$ 255,658,000.00

Total Shares Outstanding

174.11 Millions

174,109,000

Average Daily Trading Volume

$ 839.53 Thousand

$ 839,528.00

Sector

Health

Industry

Pharmaceutical Products

ATRS

ATRS revenue and profits

Financial Results ATRS

DRAG THE FRAME TO SEE MORE DATA

ATRS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 77.30 20,29% (12M)

P/E

55.53

3.44%

ROE

2.35%

P/BV

1.30

CI - Cigna

$ 278.64 --13,81% (12M)

P/E

10.79

2.19%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 38.17 --37,12% (12M)

P/E

-2.81

0.00%

ROE

-33.28%

P/BV

0.94

HUM - Humana

$ 205.14 --20,95% (12M)

P/E

20.72

1.73%

ROE

6.70%

P/BV

1.39

HCA - HCA Healthcare

$ 488.00 46,66% (12M)

P/E

16.40

0.60%

ROE

-244.82%

P/BV

-40.15

LLY - Eli Lilly

$ 927.03 14,15% (12M)

P/E

40.20

0.67%

ROE

86.53%

P/BV

34.79

NVS - Novartis

$ 151.97 44,80% (12M)

P/E

20.81

4.59%

ROE

30.04%

P/BV

6.25